Essential oil (EO) of Alpinia zerumbet leaves, at non-toxic concentrations (50-300 lg/mL), did not induce genotoxicity in human leukocytes. However, at the highest concentration (500 lg/mL) tested caused a reduction in cell proliferation and viability, and an increase in DNA damage. Moreover, in vivo experiments showed that EO (400 mg/kg) did not exert mutagenicity on peripheral blood cells and bone marrow in mice. In DPPH test, EO showed scavenging effects against DPPH radicals, and other free radicals (determination of intracellular GSH and lipid peroxidation assays). Furthermore, EO was able to reduce the intracellular levels of ROS, and prevented leukocytes DNA against oxidative damage. The ability of EO to reduce H 2 O 2 toxicity was observed only when cells were treated with EO during and after exposure to H 2 O 2 . With the co-and post-treatment procedures, EO decreased the frequency of apoptotic and micronucleated leukocytes as well DNA strand breaks. However, a synergistic effect was observed in cultures exposed to 500 lg/mL EO. In conclusion, EO at concentrations up to 300 lg/mL or doses up to 400 mg/kg are not mutagenic in leukocytes and in mice, but do have antioxidative and protective effects against the cytotoxicity and clastogenesis induced by H 2 O 2 .
Genetic toxicology evaluation of essential oil of Alpinia zerumbet and its chemoprotective effects against H 2 O 2 -induced DNA damage in cultured human leukocytes The use of medicinal plant extracts has increased in the last decades in Brazil. Although little information is available on their potential health risks, studies of genotoxicity can help to evaluate the safety and effectiveness of herbal health products (Bast et al., 2002) . It is important to determine the potential genetic hazards of compounds present in medicinal plants, together with their beneficial effects to the human body. However, biological data on the medicinal properties associated with plant extracts with pharmacological activities are relatively scarce, especially regarding mutagenic potential (Lohman et al., 2001) . The world's populations in developing countries depend largely on plants for their primary health care, due to poverty and lack of access to modern medicines (Akerele, 1993; Cordell, 1995) . According to World Health Organization (2002) , about 80% of the population in developing countries rely on herbal medicines at least for their primary health care. Moreover, few plants have been scientifically assessed regarding their quality, safety and efficacy (Cavalcanti et al., 2008a) . In spite of this, there have been few studies of the Brazilian medicinal flora aimed at examining potential health risks.
Alpinia zerumbet (Pers.) B.L. Burtt & R.M. Smith (Zingiberaceae) is a perennial plant growing widely in the subtropical and tropical regions of the world. Many species of the genus Alpinia provide a variety of medicinal properties, such as A. zerumbet and Alpinia purpuratal. These species have been commercialized in the food and cosmetic industries. However, their greatest importance arises from the medicinal properties of their essential oils which have been used in folk medicine (Victório, 2011) . Some studies have reported different pharmacological properties of the essential oil of A. zerumbet, such as antihypertensive (Lahlou et al., 2003) , antinociceptive (de Araújo et al., 2005) , anxiolytic (Satou et al., 2010) , antipsychotic and antioxidant (de Araújo et al., 2011) attributes.
In Brazil, A. zerumbet is known popularly as ''colônia,'' and it is traditionally used for the treatment of intestinal disorders and hypertensive cardiovascular disease, and as an antispasmodic and anti-inflammatory agent (Leal-Cardoso and Fonteles, 1999; Zoghbi et al., 1999; Bezerra et al., 2000) , and it has been reported to possess antioxidant property (Elzaawely et al., 2007a,b) . Although Alpinia is generally believed to be well-tolerated, safety has not been well studied. Currently, there is not enough available scientific evidence for or against the use of Alpinia for any indication.
Due to the fact that A. zerumbet medicinal users employ teas and infusions prepared from its leaves (Leal-Cardoso and Fonteles, 1999) , the aim of the current study was to further evaluate the genotoxic and mutagenic effects of the essential oil (EO) of A. zerumbet on peripheral blood leukocytes (PBLs) in vitro using the alkaline single-cell gel electrophoresis test (comet assay), chromosomal aberrations (CAs) test, and the cytokinesis-block micronucleus (MN) assay, as well as on mouse bone marrow and PBLs in vivo using the MN and comet tests. Furthermore, we evaluated the antioxidant potential of EO of A. zerumbet by the 1,1-diphenyl-2-picryl-hydrazyl (DPPH) radical-scavenging assay in order to correlate it with chemopreventive effects (antimutagenesis) against oxidative damage induced by H 2 O 2 .
Materials and methods

Plant material
The leaves of A. zerumbet were collected in the municipality of Maranguape (3°59.264 0 S; 38°42.591 0 W) in Ceará State (Northeastern Brazil) during January 2008. The plant was identified by Drs. Edson Paula Nunes and Peres Martins (Department of Biology, Federal University of Ceará, Fortaleza, Brazil), and a voucher specimen (ICN: 41041) was deposited at Herbarium Prisco Bezerra (Federal University of Ceará).
Extraction
Fresh leaves of A. zerumbet (500 g) were cut into small pieces and submitted to hydrodistillation in a Clevenger-type glass apparatus during 2 h, affording a yellowish oil. The obtained oil was dried over anhydrous sodium sulfate, filtered and kept under refrigeration until the GC-MS and GC-FID analysis. The oil yield was calculated as 0.3% based on the fresh weight of the plant material (w/w).
Gas chromatography-mass spectrometry (GC-MS)
The GC-MS analysis was carried out on a Shimadzu QP5050 instrument equipped with a non-polar OV-5 fused silica capillary column (30 m Â 0.25 mm i.d., 0.25 lm film thickness), utilizing helium as carrier gas and flow rate of 1 mL/ min, with split ratio of 1:48. The injector temperature and detector temperature were set at 250 and 280°C, respectively. The oven temperature was programmed to increase from 40 to 180°C at 4°C/min, and afterwards to 280°C at 20°C/min, which was kept for 7 min. Mass spectra were recorded in a range of mass-to-charge ratio (m/z) between 30 and 450. The relative content of oil constituents was determined by peak area normalization and expressed as percentage. The volatile components were identified by comparison of their 70 eV mass spectra with those provided by a spectrometer database (Wiley L-built library) as well as comparing the fragmentation patterns with those reported in the literature (Adams, 2001 ).
Gas chromatography-flame ionization detector (GC-FID)
The GC-FID analysis was carried out on a Shimadzu GC 2010 Plus instrument equipped with a non-polar CP-Sil-8 fused silica capillary column (30 m Â 0.25 mm i.d., 0.25 lm film thickness), utilizing hydrogen as carrier gas, flow rate of 1.5 mL/ min, with split ratio 1:30. The injector temperature and detector temperature were set at 250 and 260°C, respectively. The oven temperature was programmed from 70 to 180°C at 4°C/min, afterwards it was raised to 250°C at 10°C/min, which was kept for 7 min. The relative content of oil constituents was determined by the peak area normalization and expressed as percentage. The volatile components were identified by comparison of the Kovats retention indices determined from the injection of a homologous series of n-alkanes (C 7 -C 30 ) and by means of eight authentic analytical standards (b-pinene, a-terpinene, p-cymene, 1,8-cineol, terpin-4-ol, aterpineol, caryophyllene, caryophyllene oxide) run in the same chromatographic conditions applied to sample.
Chemicals
Fetal bovine serum (FBS), phytohemagglutinin, RPMI 1640 medium, trypsin-EDTA, glutamine, penicillin and streptomycin were purchased from GIBCO Ò (Invitrogen, Carlsbad, CA, USA). Low-melting point agarose and agarose were obtained from Invitrogen (Carlsbad, CA, USA). Formamidopyrimidine DNA-glycosylase (FPG) was obtained from NewEngland BioLabs (USA). Colchicine, cytochalasin-B, methylmethanesulfonate (MMS), reduced glutathione (GSH), NADPH, glutathione reductase, 5,5 0 -dithionitrobenzoic acid (DTNB), DPPH, mixture of n-alkanes and analytical standards used in the GC-FID analysis were purchased from Sigma Aldrich Co. (St. Louis, MO, USA). Hydrogen peroxide was obtained from Vetec (Brazil). Cyclophosphamide was from ASTA MEDICA (Brazil). All other chemicals and reagents used were of analytical grade.
Peripheral blood leukocyte (PBL) isolation
Heparinized blood was collected from healthy, non-smoker donors who had not taken any medication for at least 15 days prior to sampling and who had no history of recent exposure to potentially genotoxic substances (i.e., pesticides, drugs, alcohol, tobacco) or ionizing radiation (i.e., X-rays). PBLs were isolated by the standard method of density-gradient centrifugation over Histopaque-1077. Cells were washed and resuspended in RPMI 1640 medium supplemented with 20% fetal bovine serum, 2 mM glutamine, 100 U/mL penicillin and 100 lg/mL streptomycin, at 37°C under 5% CO 2 . Phytohemagglutinin (2.5%) was added at the beginning of culture. After 24 h of culture, cells were treated with the test substances.
Inhibition of PBL proliferation (Alamar Blue test)
The Alamar Blue test was performed with PBLs (1 Â 10 6 cells/mL) after 48 h exposure to the test substances. The sample (50-500 lg/mL) dissolved in saline was added to each well, and the cells were incubated for 48 h. Control groups received the same amount of saline. (Ahmed et al., 1994) .
DPPH radical-scavenging assay
The free radical scavenging activity of test substances was measured using DPPH by the method of Blois (1958) . A solution of DPPH (0.1 mM) in ethanol was prepared and added to various quantities of EO (50, 100, and 300 lg/mL) directly in wells of a multi-well plate. After 30 min, absorbance was measured at 517 nm.
Ascorbic acid (150 lM) was used as the reference. All tests were performed in triplicate. DPPH radical-scavenging capacities (%) of test substances were calculated using the following equation:
%Scavenging ¼ control absorbance-sample absorbance control absorbance Â 100
PBL treatments
For conventional genotoxic and mutagenic experiments, PBLs (5 Â 10 5 cells/mL)
were treated with increasing concentrations (50-500 lg/mL) of EO dissolved in saline (0.9%) or MMS (4 Â 10 À5 M) dissolved in DMSO (0.1%), without FBS, for 24 h at 37°C in a humidified atmosphere containing 5% CO 2 . In addition, EO of A. zerumbet was tested for its antioxidant potential in exerting an antimutagenic effect. The cytokinesis-block MN test and alkaline version of the comet assay were carried out in PBLs (0.5 Â 10 6 cells/mL) exposed to 150 lM H 2 O 2 for 1 h, along with pre-, co-, or post-treatment with EO at concentrations ranging from 50 to 500 lg/mL (without FBS), in order to correlate the possible mechanism of modulation (intra-and extracellular reactions) and effect on DNA repair. In the pre-treatment protocol, EO-treated cells (3 h) were washed with PBS, pH 7.4, and exposed to H 2 O 2 for 1 h. In co-treatment protocol, PBLs were treated, at same time, with EO and H 2 O 2 during 1 h. In the post-treatment protocol, H 2 O 2 -exposed PBLs (1 h) were washed with PBS before being treated with different EO concentrations for 3 h. In these sets of experiments, cell viability and apoptosis induction were also monitored.
Measurement of intracellular GSH content
After H 2 O 2 (150 lM for 1 h) challenge (pre-, co-, and post-treatment protocols described above), the GSH content was determined by a spectrophotometric assay based on the formation of 5-thio-2-nitrobenzoate (TNB) from DTNB, according to Akerboom and Sies (1981) with minor modification. Briefly, treated (100 and 300 lg/mL EO) and untreated PBLs (1.5 Â 10 6 cells/mL) were washed with ice-cold PBS, resuspended in 0.1 M sodium phosphate-5 mM EDTA, pH 8.0, and sonicated to obtain the cell homogenate. An equal volume of 2 M HClO 4 -4 mM EDTA was added to the cell extract, and the precipitated proteins were pelleted by centrifugation at 8000g for 15 min at 4°C. The supernatant was neutralized with 2 M KOH, and the insoluble residue was removed by centrifugation under the same conditions. For spectrophotometric determination, 910 lL of the cell extract supernatant or of a standard GSH solution, in the same phosphate-EDTA buffer, were mixed with 50 lL of 4 mg/mL NADPH in 0.5% (w/v) NaHCO 3 , 20 lL of 6 U/mL glutathione reductase in phosphate-EDTA buffer, and 20 lL of 1.5 mg/mL DTNB in 0.5% NaHCO 3 . The increase in absorbance was measured at 412 nm. The results were normalized by protein content (Lowry et al., 1951) , and were expressed as lg/mg protein.
Lipid peroxidation-TBARS assay
After H 2 O 2 (150 lM for 1 h) challenge (pre-, co-, and post-treatment protocols described above), the extent that test samples induced lipid peroxidation was determined by the reaction of thiobarbituric acid (TBA) with malondialdehyde (MDA), a product formed by lipid peroxidation (Draper and Hadely, 1990) . The assays were performed according to Salgo and Pryor (1996) , with minor modifications. Cells were incubated with the test samples for 3 h and then lysed with 15 mM Tris-HCl for 1 h. Two milliliters of trichloroacetic acid (0.4 mg/mL) and HCl (0.25 M) were added to the lysate, which was then incubated with 6.7 mg/mL TBA for 15 min at 100°C. The mixture was centrifuged at 750g for 10 min. As TBA reacts with other products of lipid peroxidation in addition to MDA, results are expressed in terms of thiobarbituric reactive species (TBARS), which are determined by absorbance at 532 nm. Hydrolyzed 1,1,3,3-tetramethoxypropane was used as the standard. The results were normalized by protein content (Lowry et al., 1951) .
Cell viability and morphological characterization of apoptotic PBLs
Cell viability was determined by the trypan blue dye exclusion test. After treatment, trypan blue-excluding cells in samples taken from cultures were counted in a Neubauer chamber. The percentage of viable cells was then calculated (Cavalcanti et al., 2008b) . Apoptotic cells were determined after each treatment by the acridine orange (AO)/ethidium bromide (EB) staining assay: 25 lL of the cell suspension were mixed with 1 lL of the staining solution (100 lg/mL AO + 100 lg/mL EB in PBS) and spread on a slide, where 300 cells were counted per data point. The percentage of apoptotic cells was then calculated (McGahon et al., 1995) .
In vitro alkaline comet assay
The alkaline comet assay was performed as described by Singh et al. (1988) with minor modifications (Hartmann and Speit, 1997) , and following the recommendations of the International Workshop on Genotoxicity Test Procedures (Tice et al., 2000) . At the end of the treatment, cells were washed with ice-cold PBS, detached with 100 lL trypsin (0.15%) and resuspended in complete RPMI medium. Next, 20 lL of cell suspension ($10 6 cells/mL) were mixed with 100 lL of 0.75% low melting point agarose and immediately spread onto a glass microscope slide precoated with a layer of 1% normal melting point agarose. The agarose was allowed to set at 4°C for 5 min. The slides were incubated in ice-cold lysis solution (2.5 M NaCl, 10 mM Tris, 100 mM EDTA, 1% Triton X-100 and 10% DMSO, pH 10.0) at 4°C for a minimum of 1 h to remove cellular proteins, leaving the DNA as ''nucleoids.'' After the lysis procedure, the slides were placed on a horizontal electrophoresis unit. The unit was filled with fresh buffer (300 mM NaOH and 1 mM EDTA, pH > 13.0) to cover the slides for 20 min at 4°C to allow DNA unwinding and expression of alkali-labile sites. Electrophoresis was carried out for 20 min at 25 V and 300 mA (0.86 V/cm). After electrophoresis, the slides were neutralized (0.4 M Tris, pH 7.5), stained with ethidium bromide (20 lg/mL) and analyzed using a fluorescence microscope.
All the above steps were conducted under yellow light or in the dark to prevent additional DNA damage. Images of 100 randomly selected cells (50 cells from each of two replicate slides) were analyzed for each concentration of test substance. Cells were scored visually and assigned to one of five classes, according to tail size (from undamaged-0, to maximally damaged-4), and a damage index value was calculated for each sample of cells. Damage index thus ranged from 0 (completely undamaged: 100 cells Â 0) to 400 (with maximum damage: 100 cells Â 4) (Collins, 2004) . The frequency of tailed cells, a DNA damage frequency indicator, was calculated based on the number of cells with tails (DNA strand breaks) vs. those without.
Measurement of oxidized purines and of intracellular reactive oxygen species (ROS)
Oxidized purines and ROS production were estimated by the alkaline comet assay (as described above) and by using 2 0 ,7
as fluorescence probe, respectively, after H 2 O 2 (150 lM for 1 h) challenge (pre-, co-, and post-treatment protocols described above). For comet assay, briefly, the slides were removed from the lysis solution, and washed three times in enzyme buffer (40 mM HEPES, 100 mM KCl, 0.5 mM Na 2-EDTA, 0.2 mg/mL BSA, pH 8.0), drained, and incubated with 70 lL FPG (30 min 37°C). Images of 100 randomly selected cells (50 cells from each of two replicate slides) were visually analyzed per group. The amount of oxidized purines (FPGsensitive sites) was then determined by subtracting the amount of strand breaks (samples incubated with buffer alone) to the total amount of breaks obtained after incubation with FPG according to da Silva Júnior et al. (2011) .
For ROS detection, at the end of the treatments, cells were incubated with 20 lM H2-DCFDA for 30 min in the dark at 37°C. Then, cells were then harvested, washed and re-suspended in PBS and analyzed immediately via flow cytometry (Guava EasyCyte Mini; Guava Technologies, Inc., Hayward, CA, USA). H 2 DCFDA diffuses through the cell membrane readily and is hydrolyzed by intracellular esterases to non-fluorescent dichlorofluorescin (DCFH), which is then rapidly oxidized to highly fluorescent DCF (2 0 ,7 0 -dichlorofluorescein) by a broad range of intracellular oxidative stresses other than H 2 O 2 (Hempel et al., 1999) . DCF fluorescence intensity is proportional to the amount of ROS formed intracellularly (LeBel et al., 1992) .
Chromosomal aberrations (CAs) test
After the end of treatment, PBLs were washed with ice-cold PBS and recultivated in complete RPMI medium for 48 h. Colchicine (0.0016%) was added 2 h before fixation (72 h). Chromosomes were prepared according to standard procedures (Moorhead et al., 1960) . Hypotonic treatment with KCl (0.75 M, 37°C) was applied for 15 min. The cells were fixed with methanol/acetic acid (3:1), and the fixative solution was changed twice. Air-dried slides were stained with Giemsa (5%, pH 6.8) for 10 min and scored for CAs according to Savage (1976) . Gap cells were also recorded, but not considered for the evaluation of mutagenicity. MMS (4 Â 10 À5 M) was used as the positive control. Only well-spread metaphases were examined. One hundred and fifty metaphases per culture were analyzed for the presence of CAs. The mitotic index was determined for 2000 cells and given as the number of mitoses per 100 cells (%) (Arni and Hertner, 1997) .
Cytokinesis-block micronucleus (MN) assay
After treatment, PBLs were washed twice with medium, and cytochalasin-B (3 lg/mL) was added to the cultures at 44 h post-initiation, as described by Fenech (2000) . Cells were harvested 72 h after the treatment starting point, resuspended in 75 mM KCl, kept at 4°C for 3 min (mild hypotonic treatment), and fixed with cold methanol/acetic acid (3:1) solution. This fixation step was repeated twice, and finally, the cells were resuspended in a small volume of methanol/acetic acid and dropped onto clean slides. Slides were stained with 10% Giemsa (pH 6.8) for 6 min, mounted and coded prior to microscopic analysis. Micronuclei were counted in 2000 binucleated cells (BNC) with well-preserved cytoplasm. The identification of MN was carried out according to Fenech (2000) .
Animals and experimental design
Male and female Swiss mice, 7 weeks old, weighing approximately 25 g, were obtained from the Federal University of Ceará animal house and submitted to 1 week of acclimatization. The animals were maintained in an experimental room under controlled conditions of temperature (22 ± 2°C), humidity ($60°C) and a 12-h light/dark cycle, with ad libitum access to food and water. The assays were performed using 5 animals/group. EO at 400 mg/kg was administered by the oral route. The negative and positive control groups received orally saline and cyclophosphamide (25 mg/kg), respectively. All treatments consisted of a single oral dose. Bone marrow samples were obtained from the mice at 24 and 48 h after the administration of the test substances. All procedures were carried out in accordance with the NIH Guide for the Care and Use of Laboratory Animals and the Brazilian Society for Neuroscience and Behavior (SBNeC) recommendations for animal care.
Mouse bone marrow micronucleus (MN) test
Before the animals were sacrificed, both femora were dissected and the marrow cells were flushed out with 1 mL of fetal bovine serum and pipetted up and down several times. The cell suspension was centrifuged at 1000 rpm for 5 min, the supernatant was removed, and the cell pellet was resuspended and placed on a clean glass slide. The preparations were dried overnight, covered with concentrated Leishman's stain for 3 min and counter-stained with diluted Leishman's stain (1:6) for 15 min. The slides were scored under a light microscope at 40Â magnification. The percentage of micronucleated cells was determined relative to a differential blind count of 2000 polychromatic erythrocytes (PCEs) per animal (Ramos et al., 2008) .
In vivo alkaline comet assay
For the in vivo comet assay, the experimental design was the same as for the MN test in mice. Peripheral blood was collected in heparinized capillary tubes and kept on ice until use. The comet assay was conducted under alkaline conditions (pH > 13). The experiments were carried out according to the protocol of Hartmann et al. (2003) . Five animals were used per experimental group, and three slides were prepared from each blood sample. The experimental procedure and analysis of the cells were performed as described above.
Statistical analysis
All experiments were performed in triplicate in three independent experiments. All statistical analyses were carried out using the GRAPHPAD program (Intuitive Software for Science, San Diego, CA). For the analysis of DPPH radical-scavenging capacity, cell viability and proliferation, apoptosis induction, and comet and cytokinesis-block MN assays, data of normal distribution were compared by analysis of variance (ANOVA) followed by Tukey's test. For induction of in vitro CAs data of normal distribution were compared by ANOVA followed by the paired Student's t-test. Data of normal distribution from the in vivo MN test were compared by ANOVA followed by Dunnett's test.
Results
GC/MS and GC-FID analysis analysis of essential oil of A. zerumbet
The GC/MS and GC-FID analysis of the hydrodistilled EO from A. zerumbet leaves permitted the detection and identification of sixteen constituents, 14 of which were monoterpenes (98.23%), along with two sesquiterpenes (1.77%) (Table 1) . 1,8-Cineol (22.40%) and p-cymene (18.91%), terpinen-4-ol (17.32%) were the major compounds of the A. zerumbet oil. These data are in agreement with those reported in the literature (Lahlou et al., 2003; Murakami et al., 2009; Victório et al., 2010) .
3.2. DPPH radical-scavenging activity and variation on intracellular GSH pool after A. zerumbet's essential oil exposure 1,1-Diphenyl-2-picryl-hydrazyl radical (DPPH Å ), an organic free radical, was used to study the free radical-scavenging capacity of EO of A. zerumbet. DPPH Å is considered to be a model for the lipophilic radical. A chain reaction in lipophilic radicals is initiated by lipid autoxidation (Blois, 1958; Kumar et al., 2005) . The positive DPPH test suggests that EO contains free radical scavengers. The scavenging effects of EO on DPPH Å are illustrated in Fig. 1 . EO had significant (p < 0.05) scavenging effects on DPPH Å which increased with increasing concentration in the 50-300 lg/mL range. The scavenging capacity of control (saline) was zero, while EO at the lowest concentrations (50 and 100 lg/mL) scavenged DPPH Å by about 32.25 ± 4.78% at 50 lg/mL and 65.14 ± 3.78% at 100 lg/mL.
At the highest concentration of EO, the scavenging capacity was similar to that of vitamin C (ascorbic acid) at 150 lM. The DPPH radical-scavenging capacity (%) for EO at 300 lg/mL was 80.15 ± 2.08%, and for vitamin C 85.33 ± 6.17%.
As seen in Tables 2 and 3 , EO (100 and 300 lg/mL) did not reduce intracellular GSH levels, and did not induce an increase in the oxidative stress markers after 3-h treatment, while H 2 O 2 caused a statistically significant decrease in GSH content, and provoked an increase on intracellular ROS generation and lipid oxidation products (MDA formation), as well an increase in the purine bases oxidation after 1 h incubation. After H 2 O 2 challenge, only co-treatment preserved the intracellular GSH levels at control values, and also prevented the ROS formation, lipid peroxidation, and the oxidation of nucleotidic bases. EO pre-incubation or postincubation did not prevent the decrease in GSH content (Table 2) and the others events of oxidative stress (Table 3 ).
In vitro cytotoxic, genotoxic, and mutagenic effects of essential oil of A. zerumbet in PBLs
After 48 h exposure, the Alamar Blue assay and trypan blue dye exclusion test showed that EO of A. zerumbet did not elicit any significant antiproliferative or toxic effects on PBLs cultures at concentrations up to 300 lg/mL. However, cultures exposed to the highest concentration (500 lg/mL) of EO showed a decrease in the proliferation rate and viability of PBLs (Fig. 2) . The preceding findings correlated well with the results of genotoxic (comet assay) and mutagenic (MN and CAs) assays. EO was not able to increase DNA strand breaks (Fig. 3 ) and the frequency of aberrant PBLs (Table 4) and micronucleated PBLs, and did not reduce the cytokinesis-block proliferation index (Table 5) , at concentrations ranging from 50 to 300 lg/mL. On the other hand, at the highest concentration, EO caused a significant increase in the cell DNA damage index and in the frequencies of tailed, aberrant, and micronucleated PBLs, and decrease in the cytokinesis-block proliferation index. In CAs evaluation, the most frequent alterations found were chromosome and chromatid breaks and gaps. Rearrangements such as dicentric and ring chromosomes and triradial figures were not observed. As expected, the exposure of PBLs to the alkylating agent MMS resulted in a significant increase in DNA strand breaks (31.24-fold) as well as in the number of aberrant cells (16.81-fold) and micronucleated cells (17.50-fold) when compared to the negative control (saline).
Effects on H 2 O 2 challenge
The ability of non-toxic (50-300 lg/mL) and toxic concentrations (500 lg/mL) of EO to reduce H 2 O 2 toxicity as measured by the trypan blue assay and AO/EB DNA-binding fluorescent dyebased approach was determined. Figs. 4 and 5 show that H 2 O 2 (150 lM) cytotoxicity (decreased viability and apoptosis induction) was significantly attenuated by non-toxic concentrations of EO in co-, and post-treatment protocols, respectively. However, EO at 500 lg/mL significantly enhanced H 2 O 2 -induced cytotoxic effects (p < 0.05). The effect of the test substances on H 2 O 2 -induced DNA damage is shown in Tables 6 and 7, along with the mutagenic and antimutagenic effects of EO determined by the cytokinesisblock MN assay after co-, and post-exposure, respectively. As expected, PBLs treated with 150 lM H 2 O 2 exhibited severe DNA damage, as demonstrated by the increase in DNA damage index. When PBLs were co-or post-exposed to non-toxic concentrations of EO, the levels of DNA strand breaks were significantly reduced (p < 0.05). Also, permanent DNA damage was reduced at concentrations up to 300 lg/mL, as shown by the concentrationdependent decrease in micronucleus rate. In contrast, a synergistic effect was observed in PBLs co-, and post-treated at the highest concentration of EO. These results obtained by co-or postexposure protocols indicated that treatment with EO of A. zerumbet at non-toxic concentrations (50-300 lg/mL) protected PBLs against the mutagenic oxidative effects of H 2 O 2 . On the other hand, pre-treatment (EO) did not protect PBLs against the cytotoxic (Fig. 6A) and clastogenic effects of H 2 O 2 (Figs. 6B and C).
Essential oil of A. zerumbet lack genotoxic and mutagenic effects in mice
In the comet assay, peripheral blood was collected 24 and 48 h after the administration of the test substances. The results of the genotoxicity test in mouse peripheral blood cells after EO treatment are shown in Fig. 7 . Analysis within the 24 and 48-h groups did not show any significant increase in the DNA damage index. The levels of DNA strand breaks in groups sacrificed at 24 and 48 h after treatment were similar to control levels (saline). Table 8 showed that there was no significant increase in the incidence of micronucleated polychromatic erythrocytes (MNPCEs) in bone marrow of male and female mice treated with EO at 400 mg/kg. Moreover, in all sets of experiments, no statistical differences in DNA damage levels and MNPCEs frequencies between sexes were observed in cells collected at different times (24 and 48 h) after EO administration.
Discussion
Species of the genus Alpinia are extensively used for medicinal purposes in various parts of Asia and the Americas. Despite the popularity of A. zerumbet as an herbal remedy and the documented efficacy of its EO, the plant and its EO have received little scientific attention (de Araújo et al., 2005) . The use of plants for the treatment of diseases continues to rise, although there are few studies providing proof of these effects. Previous studies have also indicated that some substances present in some medicinal plants are potentially toxic and carcinogenic (de Sá-Ferreira and Vargas, 1999) , and it has also been reported that some traditional medicines may have a genotoxic potential (Sohni et al., 1994; Basaran et al., 1996; Romero-Jimenez et al., 2005; Cavalcanti et al., 2006; Demma et al., 2009 ). Assessment of the potential genotoxicity of traditional medicines is indeed an important issue, since damage to genetic material may lead to critical mutations and therefore to an increased risk of cancer and other diseases (Demma et al., 2009 ).
According to Faust et al. (2004) , comet assay results generally agree with the findings of one or more cytogenetic assays such as chromosomal aberrations (CAs), micronucleus (MN) and sister chromatid exchange. Therefore, in the present study, to evaluate the magnitude of DNA damage, we used the alkaline version of the comet assay. This test is a sensitive method for detecting DNA strand breaks in individual cells (Collins, 2004) . The present results indicate that EO of A. zerumbet did not exert genotoxic effects (DNA strand breaks) on human PBLs in vitro as well as peripheral blood cells of mice treated with non-toxic concentrations or dose. For mutagenic studies, we performed the in vitro CAs test as well the in vitro and in vivo MN assay, in which the latter is a very accurate and efficient tool to detect CAs as micronuclei (Cavalcanti et al., 2008b; Ramos et al., 2008) . In both situations (in vitro and in vivo experiments), EO was not able to increase the frequency of aberrant and micronucleated PBLs or PCEs. The lack of in vivo mutagenic effect of EO of A. zerumbet corroborates the findings of Dias and Takahashi (1994) , who showed that A. nutans Rosc (150-1200 mg/kg) was also devoid of mutagenic potential in a rodent model (Rattus norvegicus). Moreover, in PBL cultures exposed to EO of A. zerumbet, the proliferative rate (% BNC) was not affected by treatments at non-toxic concentrations (50-300 lg/mL), which agrees with the cytotoxicity data in the Alamar Blue, mitotic index, and cell viability (trypan blue dye exclusion) assays.
In contrast, the exposure of PBL cultures to the highest concentration (500 lg/mL) caused an increase in the levels of DNA damage and in the frequencies of cytogenetic abnormalities (CAs and MN). These DNA damage effects observed in PBL cultures treated with the highest concentration may be related to the toxic effects observed in our cytotoxicity and cell viability tests. It has been reported that besides primary DNA damage, secondary effects such as DNA strand-breaks indirectly induced as a consequence of cytotoxicity may also lead to an increase in DNA migration (Hartmann and Speit, 1997; Henderson et al., 1998; Hartmann et al., 2001) .
Nowadays, cancer is one of the mortality factors in the world that occurs as a result of different causes, such as mutagenic and carcinogenic chemicals in the environment. The prevention of cancer and other related diseases can be achieved by avoiding expo- sure to known mutagenic/carcinogenic agents, as well as by the consumption of protective factors or by chemoprevention, which involves the strengthening of physiological defense mechanisms through diet intervention or the use of drugs in the host organism (De Flora, 1998) . Understanding the actions of antimutagenic agents can contribute to the prevention of tumors in individuals exposed to different mutagenic agents. During normal cell metabolism, free radicals are produced at a high rate, but antioxidant defense systems or chemopreventive agents quench or minimize the production of free radicals and thereby protect cells from oxidative damage (i.e., DNA, proteins, plasma membrane). Many plant extracts have demonstrated potent cancer chemopreventive properties (Block, 1992; Ames and Gold, 1998; Lambert and Yang, 2003) . Most of these extracts are known to exert their effects through antioxidant mechanisms, by either quenching reactive oxygen species (ROS), inhibiting lipid peroxidation or stimulating cellular antioxidant defenses (Park and Pezzuto, 2002; Valko et al., 2007) .
Phytochemical studies with A. zerumbet and other Alpinia species revealed the presence a variety of phenolic compounds and other chemical constituents responsible for the antioxidant properties of these plants (Mohamad et al., 2004; Shi et al., 2006; Elzaawely et al., 2007a,b) . Consumption of fruits and vegetables with high contents of antioxidative phytochemicals may reduce the risk of cancer, cardiovascular disorders and many other diseases (Shui and Leong, 2006) . Therefore, in the present study, additional efforts were made to evaluate the antioxidant, antigenotoxic and antimutagenic properties of EO of A. zerumbet. DPPH Å scavenging is a commonly used method to evaluate the ability of plant extracts to scavenge free radicals generated from the DPPH reagent (Chung et al., 2006) . In this study, only non-toxic concentrations of EO were considered. The EO of A. zerumbet showed a significant reduction of DPPH Å , starting at the lowest concentration evaluated (50 lg/mL). A high antiradical activity was observed for EO at elevated concentrations (100 and 300 lg/mL) which exhibited more than 50% reduction of DPPH Å (Fig. 1) . Moreover, co-treatment (EO + H 2 O 2 ) protected leukocytes against the oxidative action of H 2 O 2 , as evidenced by the levels of intracellular GSH (Table 2) , lipoxidation products (MDA) and ROS production, as well the low levels of oxidation of nucleotidic bases (Table 3) after treatment. Elzaawely et al. (2007a) have reported the significant presence of monoterpenes (i.e., 1,8-cineol, camphor) in the leaf oil of A. zerumbet. Additionally, in the present work, the chemical profiles of EO evaluated by GC-MS analysis showed monoterpenes as the predominant compounds. Among them, terpinen-4-ol (17.32%), 1,8-cineol (22.40%), c-terpinene (11.42%) and sabinene (9.90%) were the major compounds (Table 1 ). There are reports that these monoterpenes show antioxidant activities (Grassmann, 2005; Juergens et al., 2009) , and thus, it is likely that these compounds also contribute to the antioxidant effect of EO.
The mutagenic effects of ROS, particularly H 2 O 2 , which induce oxidative DNA damage, including DNA strand breaks and base modification (Valko et al., 2007) , are well documented in mammalian cells (Lastra and Villegas, 2007) . This study presents evidence that non-toxic concentrations of EO of A. zerumbet have a strong protective effect against H 2 O 2 -induced oxidative DNA damage in PBLs, as demonstrated by the comet and MN tests (Tables 6 and 7) .
Irreparable DNA damage can activate specific mechanisms of cell death by apoptosis (Wang, 2001) . The DNA lesions induced by H 2 O 2 promoted apoptosis in PBLs, consequently leading to a reduction in cell viability (Figs. 4-6 ). Co-treatment (Fig. 4) and post-treatment ( Fig. 5 ) with EO at concentrations ranging from 50 to 300 lg/mL increased cell viability due to reduced frequencies of apoptotic cells. Our data suggest that the antimutagenic effects during co-treatment with H 2 O 2 may be due to the scavenging of free radicals and complexation of extracellular mutagenic compounds, while the protective effects in post-treatment may be due to the stimulation of DNA repair and/or reversal of DNA damage. Indeed, a number of monoterpenes, including camphor, eucalyptol and thujone, act as bioantimutagens by stimulating DNA repair (Nikolíc et al., 2011a) or act as desmutagens (i.e., linalool, myrcene and eucalyptol) through protection against oxidative DNA damage (Nikolíc et al., 2011b) .
The antioxidant potential of EO correlated with its activity against the mutagenicity of H 2 O 2 in PBLs, but only with treatment with EO during and after H 2 O 2 exposure. Unexpectedly, in pretreatment experiments, EO caused an increase in H 2 O 2 mutagenicity or had a co-mutagenic effect (Fig. 6 ). In contrast, Houghton et al. (2007) reported that different extracts (aqueous and alcoholic) of A. officinarum and A. galanga induced glutathione-S-transferase activity in cultured hepatocytes (Hep G2 cells), and postulated that this could contribute to the antioxidant potential of Alpinia extracts. On the other hand, in pre-treatment protocols, washing PBLs with phosphate buffer (pH 7.4) before plating may cause a loss of nutrients and may alter the pH of the cell culture, and this could cause inactivation of antimutagenic compounds, i.e., the antioxidant components present in the EO of A. zerumbet. In summary, the results obtained in this work allow us to conclude that EO of A. zerumbet at non-toxic concentrations (50-300 lg/mL) or dose (400 mg/kg) has no DNA damaging or mutagenic effects in cultured human leukocytes or in mice (bone marrow and whole blood) under the conditions of the assays. Also, EO from A. zerumbet has antioxidative and protective effect against the cytotoxicity, genotoxicity, and mutagenicity of H 2 O 2 . Due to the fact that A. zerumbet is widely used as teas and infusions, further studies designed to isolate, identify, and characterize their active antioxidant constituents should provide a greater understanding of the in vivo mechanisms underlying the antioxidant and antimutagenic properties of A. zerumbet.
